Skip to Content
614

Alexion Pharmaceuticals

  • Previous Rank656
  • Revenues ($M)$4,131.2
  • Revenue Percent Change16.3%
  • Profits ($M)$77.6
  • Profits Percent Change-82.5%
  • Assets ($M)$13,931.9
  • Employees2,656
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Ludwig N. Hantson Ph.D.
CEO Title
Chief Executive Officer & Director
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Boston, Mass.
Websitehttp://www.alexion.com
Years on Fortune 500 List-
Employees2,656

Alexion Pharmaceuticals Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$4,131.216.3%
Profits ($M)$77.6-82.5%
Assets ($M)$13,931.9-
Total Stockholder Equity ($M)$9,165.3-

Profit Ratios

Profit as % of Revenues1.9%
Profits as % of Assets0.6%
Profits as % of Stockholder Equity0.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0.35
EPS % Change (from 2017)-82.2%
EPS % Change (5 year annual rate)-22.7%
EPS % Change (10 year annual rate)5.8%

Total Return

Total Return to Investors (2018)-18.6%
Total Return to Investors (5 year, annualized)-6.0%
Total Return to Investors (10 year, annualized)18.3%